XML 52 R28.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Subsequent event | 12 Months Ended
--- | ---
Dec. 31, 2015
Subsequent Events [Abstract] |
Subsequent event | Note 19 — Subsequent event 2016 Manufacturing Footprint Realignment Plan On February 23, 2016, the Board of Directors of the Company approved a restructuring plan (the “Plan") designed to reduce costs, improve operating efficiencies and enhance the Company’s long term competitive position. The Plan, which was developed in response to continuing cost pressures in the healthcare industry, involves the consolidation of operations and a related reduction in workforce at certain of the Company’s facilities, and will primarily include the relocation of certain manufacturing locations and relocation and outsourcing of certain distribution operations. These actions will commence in the second quarter 2016 and are expected to be substantially completed by the end of 2018. The Company estimates that it will incur aggregate pre-tax charges in connection with the Plan of between approximately $34 million to $44 million, of which an estimated $27 million to $31 million are expected to result in future cash outlays. Most of these charges are expected to be incurred prior to the end of 2018. The following table provides a summary of the Company's current cost estimates by major type of expense associated with the Plan:
Type of expense | Total estimated amount expected to be incurred
Employee termination benefits | $14 million to $18 million
Facility closure and other exit costs (1) | $2 million to $3 million
Accelerated depreciation charges | $10 million to $13 million
Other (2) | $8 million to $10 million
| $34 million to $44 million
(1) Includes costs to transfer product lines among facilities and outplacement and employee relocation costs. (2) Consists of other costs directly related to the Plan, including project management, legal and other regulatory costs. As the Plan is implemented, management will reevaluate the estimated expenses and charges set forth above, and may revise its estimates, as appropriate, consistent with generally accepted accounting principles.

X
- References No definition available. + Details
Name: | us-gaap_SubsequentEventsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business. + References No definition available. + Details
Name: | us-gaap_SubsequentEventsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration